Delivery Order SPE2DB20D1110-SPE2DB25FK28B

This is a $1,671.20 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of EMGALITY 120 MG/ML PENML, a prescription medication, to support federal healthcare requirements. The delivery order is part of a larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999, that enables the agency to efficiently procure a comprehensive range of...

This federal contract award, with ID SPE2DB22D3016|SPE2DB25FAEF7, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EMGALITY 120 MG/ML PENML, a pharmaceutical product, with a ceiling value of $16,022.52 and a completion date of November 22, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and there is no set-aside designation...

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of EMGALITY 120 MG/ML PENML, a pharmaceutical product. The contract has a ceiling value of $1,296.75 and a period of performance through March 31, 2025. The contract is a Firm Fixed Price (FFP) type and does not have a set-aside designation, indicating open competition....

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,671.20, is for the supply of EMGALITY 120 MG/ML PENML, a prescription medication. The delivery order has a firm fixed price and is set to be completed by October 25, 2024. While the original solicitation is not provided, the contract is part of a larger Indefinite Delivery Contract (IDC) valued at...

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $1,226.78. The contract is for the delivery of EMGALITY 120 MG/ML PENML, a pharmaceutical product, with a period of performance through July 1, 2025. The contract is a firm-fixed-price delivery order, without a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp also holds a larger...

The Defense Logistics Agency awarded a firm fixed price delivery order valued at $417.27 to Amerisourcebergen Drug Corporation for the provision of 4561543535, identified as EMGALITY 120 MG/ML PENML. The order was placed under an existing Prime Vendor contract vehicle to supply pharmaceutical products and services to DOD and other federal customers. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with all work to be completed between July 19-20, 2023. No...

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EMGALITY 120 MG/ML PENML, a prescription medication. The contract has a ceiling value of $1,729.00 and a period of performance through April 17, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...

This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,729.00 firm fixed-price contract is for the supply of EMGALITY 120 MG/ML PENML, a medication used for the treatment of various medical conditions. The contract has an ultimate completion date of July 14, 2025 and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a...

The Defense Logistics Agency awarded a $417 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Emgality 120 mg/ml pen injectors. As the prime contractor, Amerisourcebergen will deliver the pen injectors to its place of performance in Conshohocken, Pennsylvania by September 22, 2023 under the terms of this order. Emgality is used to treat conditions such as migraine and cluster headaches. The Defense Logistics Agency leverages contracts such as this to efficiently procure...

This is a $1,729.00 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EMGALITY 120 MG/ML PENML medical supplies. It has an ultimate completion date of July 14, 2025 and is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...